The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M02 | Topical products for joint and muscular pain | |
| 3 | M02A | Topical products for joint and muscular pain | |
| 4 | M02AA | Antiinflammatory preparations, non-steroids for topical use | |
| 5 | M02AA12 | Naproxen |
| Active Ingredient | Description | |
|---|---|---|
| Naproxen |
Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| NAPROSYN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
